| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| ATC: | G03DA03 |
| UNII: | 21807M87J2 |
| InChI Key | DBPWSSGDRRHUNT-CEGNMAFCSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C21H30O3 |
| Molecular Weight | 330.47 |
| AlogP | 3.84 |
| Hydrogen Bond Acceptor | 3.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 1.0 |
| Polar Surface Area | 54.37 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 0.0 |
| Heavy Atoms | 24.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Oxidoreductase
|
- | - | - | - | 21 | |
|
Secreted protein
|
- | - | 100 | 18 | - | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC21/SLCO family of organic anion transporting polypeptides
|
- | - | - | - | 107 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Premature Birth | 2 | D047928 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEBI | 17252 |
| ChEMBL | CHEMBL1062 |
| DrugBank | DB14570 |
| EPA CompTox | DTXSID6040747 |
| FDA SRS | 21807M87J2 |
| Human Metabolome Database | HMDB0000374 |
| Guide to Pharmacology | 5104 |
| KEGG | C01176 |
| PDB | 3QZ |
| SureChEMBL | SCHEMBL8068 |
| ZINC | ZINC000005434436 |